For the Quarter Ending March 2026
Loratadine Prices in North America
- In United States, the Loratadine Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream petroleum costs.
- The Loratadine Production Cost Trend increased in March 2026 as producer prices rose 4.0% year-over-year.
- The Loratadine Demand Outlook strengthened in March 2026, supported by 4.0% retail sales growth and 3.3% consumer inflation.
- Industrial production grew 0.7% year-over-year in March 2026, keeping domestic Loratadine active pharmaceutical ingredient supply constrained.
- Steady consumer confidence at 91.8 and 4.3% unemployment in March 2026 supported consistent Loratadine retail purchases.
- The Manufacturing Index expanded in March 2026, reflecting robust procurement activity for Loratadine formulation and packaging.
- Upstream petroleum product prices for Loratadine's toluene solvent surged in Q1 2026 due to Middle Eastern disruptions.
- Import reliance for Loratadine active pharmaceutical ingredients strengthened in Q1 2026, prompting federal actions for onshore production.
- The Loratadine Price Forecast indicated an upward trajectory in Q1 2026 as buyers secured supply before tariffs.
Why did the price of Loratadine change in March 2026 in North America?
- Upstream petroleum product prices for Loratadine's toluene solvent spiked in March 2026 amid shipping disruptions.
- Domestic stockpiles of Loratadine active pharmaceutical ingredients weakened in Q1 2026 due to import reliance.
- Elevated producer prices in March 2026 increased the cost of complex organic synthesis and materials.
Loratadine Prices in APAC
- In China, the Loratadine Price Index rose quarter-over-quarter in Q1 2026, driven by surging regional toluene feedstock costs.
- The Loratadine Production Cost Trend increased significantly in March 2026 as the Producer Price Index rose by 0.5%.
- The Loratadine Demand Outlook remained relatively stable in March 2026 because the Consumer Price Index increased by 1.0%.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, reducing overall consumer OTC pharmaceutical medication purchases.
- Consumer confidence hit 91.6 in February 2026, which directly dampened preventative seasonal allergy medication retail sales volumes.
- Industrial production grew 5.7% in March 2026, ensuring ample market availability of bulk pharmaceutical chemical manufacturing precursors.
- The Manufacturing Index expanded in March 2026, reflecting increased industrial activity within the regional pharmaceutical formulation sector.
- The Loratadine Price Forecast tracked higher in March 2026 as regional naphtha feedstock inventories depleted very rapidly.
Why did the price of Loratadine change in March 2026 in APAC?
- China toluene feedstock costs surged sharply in March 2026, elevating pharmaceutical active ingredient production expenses.
- Global crude oil prices surged in March 2026, increasing baseline costs for essential petrochemical derivatives.
- Domestic chemical supply tightened as plants reduced operating rates in February 2026, restricting precursor availability.
Loratadine Prices in Europe
- In Germany, the Loratadine Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream naphtha costs.
- The Loratadine Production Cost Trend increased in March 2026 as 2.7% CPI inflation elevated operational expenses.
- Despite the rising Loratadine Price Index, producer prices declined by -0.2% in March 2026, easing precursor pressures.
- The Loratadine Demand Outlook remained steady as the Manufacturing Index expanded during March 2026, supporting formulation activity.
- Industrial production stagnated at 0.0% in February 2026, while petrochemical operating rates weakened in March 2026.
- Retail sales grew 0.7% and unemployment held at 4.2% in February 2026, supporting OTC allergy medication purchases.
- The Loratadine Price Forecast stabilized as consumer confidence hit -24.7 in March 2026, prompting shifts toward generics.
- Naphtha feedstock costs surged and regional supply tightened in March 2026 due to severe global supply chain disruptions.
- Import availability from Asia plummeted in Q1 2026, while natural gas energy costs spiked in March 2026.
Why did the price of Loratadine change in March 2026 in Europe?
- Naphtha feedstock costs surged in March 2026 due to Middle East conflicts, elevating production expenses.
- Global supply chains experienced severe disruptions in March 2026, tightening regional petrochemical feedstock availability significantly.
- Natural gas energy costs spiked in March 2026, further increasing the overall chemical manufacturing burden.
For the Quarter Ending December 2025
Loratadine Prices in North America
- In the United States, the Loratadine Price Index rose quarter-over-quarter in Q4 2025, driven by robust consumer spending.
- Loratadine production costs increased in Q4 2025, influenced by a 3.0% year-over-year PPI rise in November 2025.
- Loratadine demand outlook strengthened as retail sales increased by 3.3% year-over-year in November 2025.
- Energy costs for Loratadine production climbed as natural gas spot prices rose in the final months of 2025.
- Consumer confidence, at 89.1 in December 2025, supported spending on healthcare products, boosting Loratadine demand.
- Industrial production increased by 2.0% year-over-year in December 2025, indicating expanding economic activity.
- U.S. business inventories, including retail and wholesale, increased in October 2025, impacting supply dynamics.
- The unemployment rate fell to 4.4% in December 2025, bolstering consumer disposable income and spending.
Why did the price of Loratadine change in December 2025 in North America?
- Rising input costs, evidenced by a 2.7% year-over-year CPI increase in December 2025, pressured Loratadine prices upward.
- Strong consumer spending, with retail sales up 3.3% year-over-year in November 2025, boosted demand for Loratadine.
- Natural gas spot prices rose in late 2025 due to a polar vortex, increasing energy-related production expenses.
Loratadine Prices in APAC
- In China, the Loratadine Price Index fell quarter-over-quarter in Q4 2025, driven by reduced production costs and subdued consumer demand.
- Loratadine production costs declined in December 2025, as the Producer Price Index fell by 1.9% year-on-year.
- Lowering general industrial power rates in China during 2025 also contributed to reduced production costs.
- Loratadine demand was subdued in Q4 2025, with retail sales growing only 0.9% year-on-year in December 2025.
- Weak consumer purchasing power, indicated by a 0.8% CPI in December 2025, impacted OTC medication demand.
- Despite cooled consumer sentiment in Q4 2025, government health expenditure increased in November 2025.
- Loratadine supply expanded in December 2025, supported by an expanding Manufacturing Index and 5.2% industrial production growth.
- Persistent overcapacity in the broader chemical industry during 2025 influenced Loratadine market dynamics.
- Chinese medicine exports, including APIs, showed steadily increasing scales in the first eleven months of 2025.
Why did the price of Loratadine change in December 2025 in APAC?
- Falling Producer Price Index by 1.9% in December 2025 reduced manufacturing input costs.
- Subdued consumer demand, with retail sales growing only 0.9% in December 2025, limited purchasing.
- Persistent overcapacity in the chemical industry during 2025 contributed to competitive pricing.
Loratadine Prices in Europe
- In Germany, the Loratadine Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer input costs in December 2025.
- Loratadine production costs trended downward in Q4 2025, as producer prices declined by 2.5% year-on-year in December 2025.
- The Loratadine demand outlook remained subdued in Q4 2025, reflecting contracting manufacturing activity in December 2025.
- Consumer confidence, at -17.5 in December 2025, negatively impacted Loratadine demand, particularly for OTC products.
- German pharmaceutical output strongly increased in October 2025, contrasting with overall weak chemical demand.
- High natural gas costs continued to challenge Loratadine production in Germany throughout Q4 2025.
- Retail sales grew 1.1% year-on-year in November 2025, offering some support for OTC Loratadine demand.
- Industrial production expanded 0.8% year-on-year in October 2025, providing slight stability to the supply chain.
- A 6.2% unemployment rate and 1.8% CPI in December 2025 pressured Loratadine demand.
Why did the price of Loratadine change in December 2025 in Europe?
- Producer input costs for Loratadine declined by 2.5% in December 2025.
- Negative consumer confidence in December 2025 dampened OTC Loratadine demand.
- High natural gas costs in Q4 2025 pressured overall production expenses.
For the Quarter Ending September 2025
North America
- In the United States, the Loratadine (Micronised) Price Index rose quarter-over-quarter in Q3 2025, driven by rising producer costs.
- Loratadine production costs increased due to a 2.6% rise in Producer Price Index year-over-year in August 2025.
- Demand for lower-cost generic active pharmaceutical ingredients strengthened in the US during Q3 2025, supporting market activity.
- US natural gas prices experienced an overall year-on-year uptick in Q3 2025, impacting manufacturing expenses.
- Retail sales, excluding auto and gas, increased 5.42% year-over-year in September 2025, bolstering demand.
- Raw materials and finished goods inventories for chemicals contracted in Q3 2025, indicating destocking.
- The 4.3% unemployment rate in September 2025 supported consumer purchasing power for over-the-counter products.
- Consumer confidence declined to 94.2 in September 2025, potentially dampening future discretionary spending.
- The Loratadine (Micronised) price forecast suggests continued upward pressure due to sustained demand and costs.
Why did the price of Loratadine (Micronised) change in September 2025 in North America?
- Rising Producer Price Index (2.6% YoY, August 2025) increased Loratadine production costs.
- Robust retail sales (up 5.42% YoY, September 2025) bolstered demand for OTC medications.
- Contracting raw material and finished goods inventories in Q3 2025 tightened supply.
APAC
- In China, the Loratadine (Micronised) Price Index faced downward pressure quarter-over-quarter, influenced by contracting manufacturing.
- Loratadine (Micronised) production costs trended upward in Q3 2025, driven by climbing input and raw material costs.
- Demand for Loratadine (Micronised) faced headwinds from a contracting Manufacturing Index and low consumer confidence.
- Deflationary pressures (CPI -0.3%, PPI -2.3% in September 2025) impacted the Loratadine (Micronised) Price Index.
- Overall chemical industry output rose 6.5% year-on-year in September 2025, despite persistent overcapacity issues.
- Retail sales increased 3.0% year-on-year in September 2025, supporting OTC Loratadine demand despite 5.2% unemployment.
- Raw material inventories for manufacturing declined in July 2025, with the decline narrowing by September.
- The Loratadine (Micronised) Price Forecast suggests continued pressure from weak consumer sentiment and manufacturing contraction.
Why did the price of Loratadine (Micronised) change in September 2025 in APAC?
- Deflationary pressures (CPI -0.3%, PPI -2.3% in September 2025) exerted downward price pressure.
- Contracting manufacturing activity and low consumer confidence (89.6 index) dampened demand in September 2025.
- Rising input costs in Q3 2025 were offset by chemical overcapacity, limiting price increases.
Europe
- In Germany, the Loratadine (Micronised) Price Index fell quarter-over-quarter in Q3 2025, due to lower producer prices in September 2025.
- Loratadine (Micronised) production costs faced downward pressure from a 1.7% decline in producer prices in September 2025.
- Demand outlook for Loratadine (Micronised) was stable, with retail sales up 0.2% in September 2025, despite rising CPI.
- Overall industrial output declined in Q3 2025, with the Manufacturing Index contracting, impacting supply chain efficiency.
- Consumer confidence showed a stabilizing trend in Q3 2025, supporting demand for over-the-counter Loratadine products.
- Elevated raw material costs for the chemical industry in Q3 2025 continued to challenge Loratadine (Micronised) manufacturers.
- Increased chemical imports into Germany in Q3 2025 intensified market competition for Loratadine (Micronised).
- The stable 6.3% unemployment rate in September 2025 indicated constrained consumer purchasing power for health items.
- Loratadine (Micronised) price forecast suggests continued pressure from softening chemical sector pricing and cost optimization efforts.
Why did the price of Loratadine (Micronised) change in September 2025 in Europe?
- Producer prices declined 1.7% in September 2025, reducing manufacturing input costs.
- Overall chemical sector pricing softened in Q3 2025, impacting market dynamics.
- Increased chemical imports into Germany in Q3 2025 intensified market competition.
